USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
AI-based Triaging and Simulation Technology to Aid Expansion of Neurointerventional Stroke Management Procedures
14-Feb-2022
Global
Market Research
K6DB-01-00-00-00
HC03502-GL-MT_26267
The global prevalence of stroke is estimated to be about 100 million as of 2021. In the past 30 years, improvements in stroke prevention, acute treatment, and neuro-rehabilitation have contributed to a significant reduction in the burden of stroke in high-income countries. Neurovascular solutions companies recognize the importance of optimized solutions at various stages for stroke management apart from just a treatment-centric approach.
Industry participants increasingly focus on solutions that address timely coordination of care between the patient and caregiver, preventive health, and first aid ambulatory care for optimal stroke care. Clinicians leverage new-age AI, robotics, and imaging technologies to improve prevention, diagnosis, and treatment.
The research study provides an overview of the global neurovascular diseases solutions (medical technology) market. This includes a 6-year global market revenue forecast for neurovascular surgical devices from 2020 to 2026.
The forecast involves a breakdown by the following surgical segments: Embolization devices, Thrombectomy devices, Angioplasty and Stenting devices, and Access devices.
The study offers a 360-degree industry perspective, covering insights on the competitive environment, technology innovations, commercial developments, regulatory updates, and recent developments in the space. Key research outcomes will focus on finding short and long-term growth opportunities in the neurovascular management industry.
Author: Kaustubh Suresh Savant
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Neurovascular Disease Management Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Definition of Disorders
Industry Segmentation
Shifting Focus in Neurovascular Disease Management
Developments in Associated Technology to Boost Neurovascular Disease Management
Key Competitors for Neurovascular Disease Management
Major Collaborations and Acquisitions
Funding in Startups
Key Product Approvals and Launches (2020–2021)
Key Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Surgical Device Segments
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis by Region
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Key Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1—Focus on Rehabilitation Neurostimulators for Product Portfolio Expansion
Growth Opportunity 1—Focus on Rehabilitation Neurostimulators for Product Portfolio Expansion (continued)
Growth Opportunity 2—Stroke Prevention Devices to Help Overcome Challenges with Medication Side Effects and Post-Procedural Incidences
Growth Opportunity 2—Stroke Prevention Devices to Help Overcome Challenges with Medication Side Effects and Post-Procedural Incidences (continued)
Growth Opportunity 3—Smart Access Solutions to Improve Treatment Success for Ischemic Stroke
Growth Opportunity 3—Smart Access Solutions to Improve Treatment Success for Ischemic Stroke (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Neurovascular Disease Management: Major Acquisitions and Collaborations, Global, 2020–2021
- Neurovascular Disease Management: Key Startup Investments, Global, 2020–2021
- Neurovascular Disease Management: Key Growth Metrics, Global, 2021
- Neurovascular Disease Management: Growth Drivers, Global, 2022–2026
- Neurovascular Disease Management: Growth Restraints, Global, 2022–2026
- Neurovascular Disease Management: Revenue Forecast, Global, 2020–2026
- Neurovascular Disease Management: Revenue Forecast by Surgical Device Segments, Global, 2020–2026
- Neurovascular Disease Management: Revenue Forecast by Region, Global, 2020–2026
- Neurovascular Disease Management: Competitive Environment, Global, 2021
- Embolization Devices: Key Growth Metrics, Global, 2021
- Embolization Devices: Revenue Forecast, Global, 2020–2026
- Thrombectomy Devices: Key Growth Metrics, Global, 2021
- Thrombectomy Devices: Revenue Forecast, Global, 2020–2026
- Thrombectomy Devices: Revenue Forecast by Region, Global, 2020–2026
- Angioplasty and Stenting Devices: Key Growth Metrics, Global, 2021
- Angioplasty and Stenting Devices: Revenue Forecast, Global, 2020–2026
- Angioplasty and Stenting Devices: Revenue Forecast by Region, Global, 2020–2026
- Access Devices: Revenue Forecast, Global, 2020–2026
- Access Devices: Revenue Forecast by Region, Global, 2020–2026
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Kaustubh Suresh Savant |
| GPS Codes | 9600-B1,9A4B-B1,9614-B1 |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Neurovascular Devices |
| Keyword 2 | disease management |
| Keyword 3 | neurovascular devices market |
| List of Charts and Figures | Neurovascular Disease Management: Major Acquisitions and Collaborations, Global, 2020–2021~ Neurovascular Disease Management: Key Startup Investments, Global, 2020–2021~ Neurovascular Disease Management: Key Growth Metrics, Global, 2021~ Neurovascular Disease Management: Growth Drivers, Global, 2022–2026~ Neurovascular Disease Management: Growth Restraints, Global, 2022–2026~ Neurovascular Disease Management: Revenue Forecast, Global, 2020–2026~ Neurovascular Disease Management: Revenue Forecast by Surgical Device Segments, Global, 2020–2026~ Neurovascular Disease Management: Revenue Forecast by Region, Global, 2020–2026~ Neurovascular Disease Management: Competitive Environment, Global, 2021~ Embolization Devices: Key Growth Metrics, Global, 2021~ Embolization Devices: Revenue Forecast, Global, 2020–2026~ Thrombectomy Devices: Key Growth Metrics, Global, 2021~ Thrombectomy Devices: Revenue Forecast, Global, 2020–2026~ Thrombectomy Devices: Revenue Forecast by Region, Global, 2020–2026~ Angioplasty and Stenting Devices: Key Growth Metrics, Global, 2021~ Angioplasty and Stenting Devices: Revenue Forecast, Global, 2020–2026~ Angioplasty and Stenting Devices: Revenue Forecast by Region, Global, 2020–2026~ Access Devices: Revenue Forecast, Global, 2020–2026~ Access Devices: Revenue Forecast by Region, Global, 2020–2026~ |
| Podcast | No |
| WIP Number | K6DB-01-00-00-00 |
Global Neurovascular Disease Management Growth Opportunities
$4,950.00
Special Price $3,712.50 save 25 %